BOLD manages a family of funds targeting investments in early stage and growth technology companies. BOLD is particularly interested in entrepreneurial leaders that leverage exponential technologies to transform the world and create innovative solutions to humanity's grand challenges.

Qubit Health Capital is dedicated to revolutionising healthcare by backing transformative technologies across the UK, Europe, and the US.

Sands Capital is an active, long-term investor in leading innovative businesses globally. The firm's approach combines rigorous fundamental analysis with creative thinking to identify high-quality growth businesses that are creating the future.

Action Potential Venture Capital (APVC) is an independent corporate venture arm of GlaxoSmithKline (GSK) that invests globally in companies developing bioelectronic medicines. This emerging field includes both non-invasive and minimally invasive therapeutic devices that stimulate or block nerve signaling to regulate organ function implicated in chronic diseases. APVC also invests in the enabling technologies that deliver this precision energy as a medicine.

Applied Ventures, LLC, the venture capital arm of Applied Materials, invests in early-stage technology companies that promise to deliver high growth and exceptional returns. The company offers startups access to new materials engineering and semiconductor technology innovations.

Creative Ventures is a U.S.-based venture capital firm investing in startups using deep technology to address global secular trends in traditional sectors.

Ferretto Capital is a professionally-run family office that focuses on generating consistent long-term returns by allocating to a globally diversified portfolio of funds, with a focus on alternatives. With a team of experienced fund managers and allocators, they combine a process-driven, institutional investment approach with the nimbleness of a family office.

Fiscus Ventures (affiliate of Magnetar Capital) looks to support innovative groundbreaking technologies that will both change the delivery and practice of clinical medicine.

HM Capital Management is a fee-only Registered Investment Advisor serving as a legal fiduciary to affluent families and Institutional Clients. HM Capital's mission is to be problem solvers, a source of solutions and the go-to person for all things financial.

Nautilus Venture Partners invests in early-stage companies with unique technology, a strong team, and market potential. Our focus includes artificial intelligence, IoT, and mobile.

OSF Ventures specializes in venture optimization, partnering financially and operationally in companies that improve patient outcomes and reduce costs to health care systems. OSF Ventures is a division of OSF HealthCare.

Page One Ventures is an early-stage venture firm centered in Silicon Valley. We believe the rise of technology companies is still at its inception and the epicenter will continue to be the San Francisco Bay Area. We build upon decades of partnership and leverage our deep global network of iconic institutions and patient capital, to invest early and give our companies international DNA and strategic advantages from the early-stage. Our Partners have previously invested in 50+ companies that have since raised over $1.8B in follow on financing and have a collective value of $20B+. We believe the future is written by entrepreneurs, not predicted by investors.

Pura Vida Investments, LLC ("Pura Vida") is a fundamentally-driven investment manager focusing on innovative and disruptive technologies, company life cycle changes, and structural shifts in the healthcare landscape. Pura Vida invests across all facets of healthcare, particularly companies that develop, produce, and commercialize innovative medical technology, diagnostics tests, genomic instruments, and bio-therapeutics.

TDK Ventures is a technology-focused venture fund, investing globally in early-stage startups that leverages fundamental material science to unlock an attractive and sustainable future for the world. TDK Ventures' goal is to help every start-up we invest to achieve their full potential for positive world impact.

For more than 50 years, Wilson Sonsini Goodrich & Rosati (WSGR) has offered a broad range of services and legal disciplines focused on serving the principal challenges faced by the management and boards of directors of business enterprises.